Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination

RR Goel, SA Apostolidis, MM Painter, D Mathew… - Science …, 2021 - science.org
mRNA vaccines for SARS-CoV-2 have been authorized for emergency use. Despite their
efficacy in clinical trials, data on mRNA vaccine–induced immune responses are mostly …

T-cell immunity to influenza in older adults: a pathophysiological framework for development of more effective vaccines

JE McElhaney, GA Kuchel, X Zhou, SL Swain… - Frontiers in …, 2016 - frontiersin.org
One of the most profound public health consequences of immune senescence is reflected in
an increased susceptibility to influenza and other acute respiratory illnesses, as well as a …

Cell culture-based influenza vaccines: A necessary and indispensable investment for the future

NR Hegde - Human vaccines & immunotherapeutics, 2015 - Taylor & Francis
The traditional platform of using embryonated chicken eggs for the production of influenza
vaccines has several drawbacks including the inability to meet the volume of required doses …

Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells

RS Herati, A Muselman, L Vella, B Bengsch… - Science …, 2017 - science.org
T follicular helper (TFH) CD4 cells are crucial providers of B cell help during adaptive
immune responses. A circulating population of CD4 T cells, termed cTFH, have similarity to …

Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012–2013

S Cobey, S Gouma, K Parkhouse… - Clinical Infectious …, 2018 - academic.oup.com
Background Influenza vaccination aims to prevent infection by influenza virus and reduce
associated morbidity and mortality; however, vaccine effectiveness (VE) can be modest …

Diminished B-cell response after repeat influenza vaccination

M Sanyal, TH Holmes, HT Maecker… - The Journal of …, 2019 - academic.oup.com
Annual vaccination with influenza vaccines is recommended for protection against influenza
in the United States. Past clinical studies and meta-analysis, however, have reported …

[HTML][HTML] Cellular immune response after vaccination in patients with cancer—Review on past and present experiences

MM Rüthrich, N Giesen, SC Mellinghoff, CT Rieger… - Vaccines, 2022 - mdpi.com
Patients with cancer are at particular risk for infection but also have diminished vaccine
responses, usually quantified by the level of specific antibodies. Nonetheless, vaccines are …

[HTML][HTML] Immunosenescence: the role of age in multiple sclerosis

AO Ibáñez, JC Laviñeta, TA Blanco - Neurología (English edition), 2023 - Elsevier
Introduction The number of elderly people with multiple sclerosis (MS) has increased in line
with population ageing. As the immune system presents profound changes over an …

Safety, immunogenicity and infectivity of new live attenuated influenza vaccines

I Isakova-Sivak, L Rudenko - Expert review of vaccines, 2015 - Taylor & Francis
Live attenuated influenza vaccines (LAIVs) are believed to be immunologically superior to
inactivated influenza vaccines, because they can induce a variety of adaptive immune …

[HTML][HTML] Systems vaccinology for a live attenuated tularemia vaccine reveals unique transcriptional signatures that predict humoral and cellular immune responses

MS Natrajan, N Rouphael, L Lai, D Kazmin, TL Jensen… - Vaccines, 2019 - mdpi.com
Background: Tularemia is a potential biological weapon due to its high infectivity and ease
of dissemination. This study aimed to characterize the innate and adaptive responses …